Dr. Alan Davis is a Clinical Psychologist and Assistant Professor of Social Work at Ohio State University and Adjunct Assistant Professor in the Center for Psychedelic and Consciousness Research at Johns Hopkins University. Dr. Davis’s clinical experience includes working with people diagnosed with trauma-based psychological problems. His research interests focus on helping those suffering with substance use and mental health problems and developing ways to conceptualize substance use and mental health problems through a strengths-based approach. Has published 60+ scientific articles and book chapters and presented research at dozens of national and international scientific conferences. Currently mentoring 12 undergraduate, graduate, and postdoctoral trainees across several universities. At Johns Hopkins, he recently completed a clinical trial of psilocybin therapy for depression and current trials exploring psychedelic treatment for patients with co-occurring alcohol use disorder and depression and patients with anorexia. At Ohio State University, he currently examines topics related to naturalistic psychedelic use among several populations including people of color who have experienced racial trauma, Spanish-speaking people, and people who use novel psychedelics such as 5-MeO-DMT. Currently building infrastructure and funding base to launch clinical trials at Ohio State University, including exploration of psilocybin therapy for treatment of PTSD among special operations veterans, psilocybin for depression among Spanish speaking people and BIPOC, and acute and enduring effects of 5-MeO-DMT in healthy humans and clinical populations.